ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
0.00%
US Tech 100
18,438.40
1.15%
S&P 500
5,307.01
0.00%
US Dollar vs CAD
1.36698
-0.16%
Bitcoin
69,876.80
1.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Reata Pharmaceuticals Inc (RETA)

  7. Reata Pharmaceuticals Inc (RETA) News

RETA

Reata Pharmaceuticals (RETA)

Reata Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RETA
DateTimeSourceHeadlineSymbolCompany
10/06/20233:07PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RETAReata Pharmaceuticals Inc
09/28/20233:30PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RETAReata Pharmaceuticals Inc
09/26/20236:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:25PMEdgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:23PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:22PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:21PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:20PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:19PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:18PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:17PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:16PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:15PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20233:14PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20237:59AMGlobeNewswire Inc.Biogen Completes Acquisition of Reata PharmaceuticalsNASDAQ:RETAReata Pharmaceuticals Inc
09/21/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RETAReata Pharmaceuticals Inc
09/21/20239:08AMBusiness WireReata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.NASDAQ:RETAReata Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RETA

Your Recent History

TSXV
EPL
Common Stock
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved